Recent Quotes (30 days)

You have no recent quotes
chg | %

ImmunoVaccine Inc.  

(Public, CVE:IMV)   Watch this stock  
Find more results for IMV
0.610
0.000 (0.00%)
Delayed:   12:47PM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.24 - 1.50
Open     -
Vol / Avg. 0.00/33,906.00
Mkt cap 48.53M
P/E     -
Div/yield     -
EPS -0.07
Shares 79.55M
Beta 5.22
Inst. own     -

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -176.58% -104.66%
Return on average equity -414.72% -212.79%
Employees 20 -
CDP Score - -

Address

Suite 412, 1344 Summer Street
HALIFAX, NS B3H 0A8
Canada
+1-902-4921819 (Phone)
+1-902-4920888 (Fax)

Website links

Description

Immunovaccine Inc. is a clinical stage vaccine development company. The Company is focusing its research and development on developing an early stage human health vaccine pipeline consisting of infectious diseases and therapeutic cancer vaccine products. The Company�s advanced vaccine candidate is DPX-0907, a multivalent therapeutic cancer vaccine targeting ovarian, breast and prostate cancers. During the year ended December 31, 2010, the Company was in a multi-site Phase I human clinical trial for DPX-0907 in the United States. The Company has developed a lipid depot-based vaccine delivery and enhancement technology called the DepoVax platform, an improvement on the Company�s original VacciMax platform. The Company has completed proof of concept pre-clinical studies in infectious disease applications, such as single-dose DepoVax platform-based pandemic influenza and hepatitis B vaccine candidates.

Officers and directors

Marc Mansour Ph.D. Chief Executive Officer, Director
Age: 39
Kimberly Stephens Chief Financial Officer, Corporate Secretary
Vicki Morgan Vice President - Business Development
Albert James Scardino Non-Executive Chairman
Age: 65
Llew Keltner M.D., Ph.D. Director
Age: 64
Stephanie M. Leouzon Director
John J. Trizzino Director
Age: 51
James W. Hall Independent Director
Age: 64